Zentalis Pharmaceuticals IncNASDAQ:ZNTL
- LAST PRICE3.5000
- TODAY'S CHANGE (%)0.2700 (8.3591%)
- Bid / Lots3.3100/ 2
- Ask / Lots3.8900/ 3
- Open / Previous Close3.3300 / 3.2300
- Day Range
- 52 Week Range
- Volume869,867
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ZNTL |
|---|---|---|
| 09:32 ET | 7831 | 3.325 |
| 09:33 ET | 8268 | 3.29 |
| 09:35 ET | 2604 | 3.46 |
| 09:37 ET | 4181 | 3.4127 |
| 09:39 ET | 9552 | 3.41 |
| 09:42 ET | 12271 | 3.47 |
| 09:44 ET | 3857 | 3.47 |
| 09:46 ET | 2218 | 3.485 |
| 09:48 ET | 2575 | 3.46 |
| 09:50 ET | 1275 | 3.46 |
| 09:51 ET | 5156 | 3.43 |
| 09:53 ET | 1723 | 3.41 |
| 09:55 ET | 12969 | 3.42 |
| 09:57 ET | 4995 | 3.42 |
| 10:00 ET | 1016 | 3.44 |
| 10:02 ET | 700 | 3.42 |
| 10:04 ET | 2700 | 3.41 |
| 10:06 ET | 2391 | 3.415 |
| 10:08 ET | 1150 | 3.4212 |
| 10:09 ET | 1810 | 3.425 |
| 10:11 ET | 1782 | 3.43 |
| 10:13 ET | 8787 | 3.43 |
| 10:15 ET | 8614 | 3.425 |
| 10:18 ET | 3262 | 3.41 |
| 10:20 ET | 1850 | 3.42 |
| 10:22 ET | 3173 | 3.445 |
| 10:24 ET | 7938 | 3.44 |
| 10:26 ET | 10529 | 3.445 |
| 10:27 ET | 6871 | 3.465 |
| 10:29 ET | 4136 | 3.495 |
| 10:31 ET | 7836 | 3.5 |
| 10:33 ET | 5928 | 3.51 |
| 10:36 ET | 7578 | 3.51 |
| 10:38 ET | 1927 | 3.53 |
| 10:40 ET | 18349 | 3.565 |
| 10:42 ET | 2199 | 3.57 |
| 10:44 ET | 3220 | 3.5812 |
| 10:45 ET | 4786 | 3.5612 |
| 10:47 ET | 3200 | 3.57 |
| 10:49 ET | 6825 | 3.582 |
| 10:51 ET | 3180 | 3.57 |
| 10:54 ET | 4109 | 3.565 |
| 10:56 ET | 1500 | 3.565 |
| 10:58 ET | 15692 | 3.565 |
| 11:00 ET | 12892 | 3.53 |
| 11:02 ET | 2799 | 3.53 |
| 11:03 ET | 2761 | 3.5489 |
| 11:05 ET | 4564 | 3.54 |
| 11:07 ET | 864 | 3.535 |
| 11:09 ET | 10396 | 3.55 |
| 11:12 ET | 800 | 3.5475 |
| 11:14 ET | 12267 | 3.55 |
| 11:16 ET | 6841 | 3.5775 |
| 11:18 ET | 7980 | 3.58 |
| 11:20 ET | 900 | 3.59 |
| 11:21 ET | 8977 | 3.595 |
| 11:23 ET | 2529 | 3.595 |
| 11:25 ET | 9132 | 3.595 |
| 11:27 ET | 5566 | 3.595 |
| 11:30 ET | 792 | 3.595 |
| 11:32 ET | 4040 | 3.575 |
| 11:34 ET | 4857 | 3.57 |
| 11:36 ET | 4399 | 3.5547 |
| 11:38 ET | 1200 | 3.53 |
| 11:39 ET | 1746 | 3.5289 |
| 11:41 ET | 1940 | 3.53 |
| 11:43 ET | 1204 | 3.535 |
| 11:45 ET | 1821 | 3.55 |
| 11:48 ET | 2638 | 3.555 |
| 11:50 ET | 4066 | 3.5171 |
| 11:52 ET | 2958 | 3.53 |
| 11:54 ET | 2100 | 3.565 |
| 11:56 ET | 9000 | 3.565 |
| 11:57 ET | 826 | 3.57 |
| 11:59 ET | 5290 | 3.565 |
| 12:01 ET | 600 | 3.555 |
| 12:03 ET | 3815 | 3.5407 |
| 12:06 ET | 3261 | 3.55 |
| 12:08 ET | 800 | 3.55 |
| 12:10 ET | 2507 | 3.55 |
| 12:12 ET | 1079 | 3.55 |
| 12:14 ET | 7240 | 3.53 |
| 12:15 ET | 3266 | 3.525 |
| 12:17 ET | 1119 | 3.53 |
| 12:19 ET | 1600 | 3.52 |
| 12:21 ET | 400 | 3.515 |
| 12:24 ET | 100 | 3.515 |
| 12:26 ET | 2566 | 3.505 |
| 12:28 ET | 1138 | 3.51 |
| 12:30 ET | 5775 | 3.5 |
| 12:32 ET | 1072 | 3.51 |
| 12:33 ET | 1784 | 3.51 |
| 12:35 ET | 300 | 3.515 |
| 12:37 ET | 100 | 3.52 |
| 12:39 ET | 2910 | 3.525 |
| 12:42 ET | 311 | 3.53 |
| 12:44 ET | 2001 | 3.525 |
| 12:46 ET | 3218 | 3.52 |
| 12:48 ET | 3800 | 3.5 |
| 12:50 ET | 100 | 3.5 |
| 12:51 ET | 1841 | 3.5 |
| 12:53 ET | 1200 | 3.52 |
| 01:00 ET | 400 | 3.515 |
| 01:02 ET | 731 | 3.52 |
| 01:04 ET | 200 | 3.52 |
| 01:06 ET | 300 | 3.52 |
| 01:08 ET | 400 | 3.52 |
| 01:09 ET | 4473 | 3.51 |
| 01:11 ET | 2272 | 3.505 |
| 01:13 ET | 4322 | 3.51 |
| 01:15 ET | 2285 | 3.52 |
| 01:18 ET | 2655 | 3.51 |
| 01:24 ET | 4075 | 3.49 |
| 01:27 ET | 300 | 3.495 |
| 01:29 ET | 200 | 3.5 |
| 01:31 ET | 4514 | 3.51 |
| 01:33 ET | 100 | 3.52 |
| 01:36 ET | 1705 | 3.525 |
| 01:38 ET | 767 | 3.5209 |
| 01:40 ET | 1000 | 3.525 |
| 01:42 ET | 200 | 3.525 |
| 01:44 ET | 307 | 3.525 |
| 01:45 ET | 4327 | 3.52 |
| 01:47 ET | 350 | 3.525 |
| 01:49 ET | 1757 | 3.52 |
| 01:51 ET | 500 | 3.52 |
| 01:54 ET | 100 | 3.515 |
| 01:56 ET | 1201 | 3.5 |
| 02:00 ET | 600 | 3.5009 |
| 02:02 ET | 1300 | 3.51 |
| 02:03 ET | 1386 | 3.515 |
| 02:05 ET | 2573 | 3.525 |
| 02:07 ET | 1615 | 3.525 |
| 02:09 ET | 500 | 3.525 |
| 02:12 ET | 800 | 3.525 |
| 02:14 ET | 300 | 3.525 |
| 02:16 ET | 500 | 3.525 |
| 02:18 ET | 400 | 3.525 |
| 02:20 ET | 2615 | 3.52 |
| 02:21 ET | 100 | 3.515 |
| 02:23 ET | 300 | 3.52 |
| 02:25 ET | 428 | 3.52 |
| 02:27 ET | 700 | 3.515 |
| 02:30 ET | 510 | 3.52 |
| 02:32 ET | 5517 | 3.52 |
| 02:34 ET | 22215 | 3.51 |
| 02:36 ET | 3524 | 3.52 |
| 02:38 ET | 1123 | 3.525 |
| 02:39 ET | 200 | 3.52 |
| 02:41 ET | 792 | 3.52 |
| 02:43 ET | 407 | 3.525 |
| 02:45 ET | 4601 | 3.51 |
| 02:48 ET | 2600 | 3.52 |
| 02:50 ET | 2052 | 3.52 |
| 02:54 ET | 200 | 3.52 |
| 02:56 ET | 200 | 3.52 |
| 02:57 ET | 808 | 3.515 |
| 02:59 ET | 6323 | 3.515 |
| 03:01 ET | 100 | 3.52 |
| 03:03 ET | 6590 | 3.51 |
| 03:06 ET | 3535 | 3.5007 |
| 03:08 ET | 2185 | 3.52 |
| 03:10 ET | 284 | 3.51 |
| 03:12 ET | 100 | 3.52 |
| 03:14 ET | 500 | 3.5197 |
| 03:15 ET | 787 | 3.515 |
| 03:19 ET | 100 | 3.515 |
| 03:21 ET | 3361 | 3.505 |
| 03:24 ET | 278 | 3.505 |
| 03:26 ET | 100 | 3.505 |
| 03:28 ET | 445 | 3.505 |
| 03:30 ET | 5489 | 3.51 |
| 03:32 ET | 2623 | 3.52 |
| 03:33 ET | 3597 | 3.52 |
| 03:35 ET | 2174 | 3.525 |
| 03:37 ET | 400 | 3.525 |
| 03:39 ET | 3564 | 3.515 |
| 03:42 ET | 800 | 3.515 |
| 03:44 ET | 730 | 3.52 |
| 03:46 ET | 1789 | 3.52 |
| 03:48 ET | 3008 | 3.515 |
| 03:50 ET | 6224 | 3.5 |
| 03:51 ET | 10825 | 3.51 |
| 03:53 ET | 2687 | 3.51 |
| 03:55 ET | 19665 | 3.505 |
| 03:57 ET | 19354 | 3.505 |
| 04:00 ET | 117997 | 3.5 |
Nov 21, 2024
Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm, from 1:14PM ET on Thursday Nov 21, 2024 by Dow Jones
1:14PM ET on Thursday Nov 21, 2024 by Dow Jones
Nov 15, 2024
DJ Zentalis Pharmaceuticals Is Maintained at Buy by Guggenheim, from 2:18PM ET on Friday Nov 15, 2024 by Dow Jones
2:18PM ET on Friday Nov 15, 2024 by Dow JonesDJ Zentalis Pharmaceuticals Price Target Maintained With a $20.00/Share by HC Wainwright & Co., from 6:54AM ET on Friday Nov 15, 2024 by Dow Jones
6:54AM ET on Friday Nov 15, 2024 by Dow Jones
Nov 13, 2024
DJ Zentalis Pharmaceuticals Adds New Executives as Efforts Around Azenosertib Sharpen, from 8:22AM ET on Wednesday Nov 13, 2024 by Dow Jones
8:22AM ET on Wednesday Nov 13, 2024 by Dow JonesPress Release: Zentalis Pharmaceuticals Announces Executive Leadership Changes Supporting Planned Registrational Clinical Studies of Azenosertib, from 8:01AM ET on Wednesday Nov 13, 2024 by Dow Jones
8:01AM ET on Wednesday Nov 13, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Zentalis Pharmaceuticals Inc | 229.7M | -1.4x | --- |
Biomea Fusion Inc | 233.4M | -1.7x | --- |
Trevi Therapeutics Inc | 223.7M | -6.6x | --- |
Quantum-Si Inc | 230.6M | -2.1x | --- |
Eledon Pharmaceuticals Inc | 239.6M | -10.4x | --- |
Perspective Therapeutics Inc | 234.0M | -3.0x | --- |
Company Information
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. The Company’s lead product candidate includes azenosertib (ZN-c3), which is a WEE1 inhibitor for advanced solid tumors and hematological malignancies. The Company is also developing a BCL-2 inhibitor, ZN-d5, for hematological malignancies and related disorders. ZN-d5 is being evaluated in combination with azenosertib in a Phase I/II dose escalation clinical trial in patients with R/R acute myeloid leukemia (AML) (ZN-d5-004C). The Company is also advancing its research on protein degraders and other undisclosed targets using its Integrated Discovery Engine.
Contact Information
- Headquarters
- 10275 Science Center Drive, Suite 200SAN DIEGO, CA, United States 92121
- Phone
- 858-263-4333
- Fax
- 302-655-5049
Executives
- Chairman of the Board
- Scott Myers
- President, Chief Executive Officer, Director
- Julie Eastland
- Senior Vice President, Finance, Interim Principal Accounting Officer and Principal Financial Officer
- Vincent Vultaggio
- Chief Scientific Officer
- Mark Lackner,
- Chief Medical Officer
- Ingmar Bruns
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $229.7M |
|---|---|
Revenue (TTM) | $40.6M |
Shares Outstanding | 71.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.78 |
EPS | $-2.53 |
Book Value | $6.18 |
P/E Ratio | -1.4x |
Price/Sales (TTM) | 5.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -515.94% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
